Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mild Cognitive Impairment in Parkinson’s Disease—What Is It?
Rimona S. Weil, Alyssa Costantini, Anette Schrag
Current Neurology and Neuroscience Reports (2018) Vol. 18, Iss. 4
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

The effect of the Mediterranean diet on cognitive function in patients with Parkinson’s disease: A randomized clinical controlled trial
Zamzam Paknahad, Elham Sheklabadi, Yeganeh Derakhshan, et al.
Complementary Therapies in Medicine (2020) Vol. 50, pp. 102366-102366
Closed Access | Times Cited: 77
Vortioxetine ameliorates motor and cognitive impairments in the rotenone-induced Parkinson's disease via targeting TLR-2 mediated neuroinflammation
Dilara Nemutlu Samur, Güven Akçay, Sendegül Yıldırım, et al.
Neuropharmacology (2022) Vol. 208, pp. 108977-108977
Closed Access | Times Cited: 24
Abnormal eye movements in Parkinson's disease: From experimental study to clinical application
Han Li, Xue Zhang, Yong Yang, et al.
Parkinsonism & Related Disorders (2023) Vol. 115, pp. 105791-105791
Closed Access | Times Cited: 13
Mild cognitive impairment in Parkinson's disease: current view
K. A. Jellinger
Frontiers in Cognition (2024) Vol. 3
Open Access | Times Cited: 4
Jiawei Kongsheng Zhenzhong Pill (JKZP) Alleviates Chronic Cerebral Hypoperfusion‐Induced Hippocampal Synaptic Damage via S100A10/tPA/BDNF Pathway
Qiaolan Wu, Yang Zhou, Chunxue Ou, et al.
Brain and Behavior (2025) Vol. 15, Iss. 2
Open Access
Insights into salt perception and cognitive impairment among middle-aged and older adults: a scoping review
Azira Sazali, Suzana Shahar, Hasnah Haron, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Parkinson’s Disease–Mild Cognitive Impairment (PD-MCI): A Useful Summary of Update Knowledge
Davide Maria Cammisuli, Salvatore Massimiliano Cammisuli, Jonathan Fusi, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 37
The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease
Hailing Liu, Bin Deng, Fen Xie, et al.
Annals of Clinical and Translational Neurology (2021) Vol. 8, Iss. 9, pp. 1917-1934
Open Access | Times Cited: 29
Pathological Correlates of Cognitive Decline in Parkinson’s Disease: From Molecules to Neural Networks
Н Ю Новиков, E. S. Brazhnik, Valentina Kitchigina
Biochemistry (Moscow) (2023) Vol. 88, Iss. 11, pp. 1890-1904
Closed Access | Times Cited: 11
Phase lag index and spectral power as QEEG features for identification of patients with mild cognitive impairment in Parkinson's disease
Menorca Chaturvedi, J.G. Bogaarts, Vitalii V. Kozak, et al.
Clinical Neurophysiology (2019) Vol. 130, Iss. 10, pp. 1937-1944
Open Access | Times Cited: 33
Pharmacological and chemogenetic orexin/hypocretin intervention ameliorates Hipp-dependent memory impairment in the A53T mice model of Parkinson’s disease
Miloš Stanojlović, Jean Pierre Pallais, Michael K. Lee, et al.
Molecular Brain (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 30
Prediction of transition from mild cognitive impairment to Alzheimer's disease based on a logistic regression–artificial neural network–decision tree model
Jie Kuang, Pin Zhang, TianPan Cai, et al.
Geriatrics and gerontology international/Geriatrics & gerontology international (2020) Vol. 21, Iss. 1, pp. 43-47
Closed Access | Times Cited: 29
A Virtual Supermarket Program for the Screening of Mild Cognitive Impairment in Older Adults: Diagnostic Accuracy Study
Mingli Yan, Huiru Yin, Qiuyan Meng, et al.
JMIR Serious Games (2021) Vol. 9, Iss. 4, pp. e30919-e30919
Open Access | Times Cited: 24
Does transcranial direct current stimulation enhance cognitive performance in Parkinson’s disease mild cognitive impairment? An event-related potentials and neuropsychological assessment study
Serkan Aksu, Atilla Uslu, Pınar İşçen, et al.
Neurological Sciences (2022) Vol. 43, Iss. 6, pp. 4029-4044
Closed Access | Times Cited: 16
Investigating the power of eyes open resting state EEG for assisting in dementia diagnosis
Jack Jennings, Luis R. Peraza, Mark R. Baker, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Exclusion of older patients from randomized clinical trials in Parkinson’s disease
D. Kłosowska, Urszula Fiszer, Jarosław Dulski, et al.
GeroScience (2024) Vol. 46, Iss. 4, pp. 3819-3830
Open Access | Times Cited: 3
A neuroimaging measure to capture heterogeneous patterns of atrophy in Parkinson’s disease and dementia with Lewy bodies
Rohan Bhome, Serena Verdi, Sophie Martin, et al.
NeuroImage Clinical (2024) Vol. 42, pp. 103596-103596
Open Access | Times Cited: 3
Evaluation of Motor and Cognitive Performance in People with Parkinson’s Disease Using Instrumented Trail-Making Test
Ram Kinker Mishra, Catherine Park, He Zhou, et al.
Gerontology (2021) Vol. 68, Iss. 2, pp. 234-240
Closed Access | Times Cited: 20
The effects of transcranial direct current stimulation on cognitive function for mild cognitive impairment: a systematic review and meta-analysis of randomized controlled trials
Othman Saleh, M Assaf, Ahmad Mohammad Alzoubi, et al.
Aging Clinical and Experimental Research (2023) Vol. 35, Iss. 11, pp. 2293-2306
Closed Access | Times Cited: 8
Manganese-Enhanced Magnetic Resonance Imaging: Overview and Central Nervous System Applications With a Focus on Neurodegeneration
Ryan Cloyd, Shon A. Koren, Jose F. Abisambra
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 27
A novel dopamine D3R agonist SK609 with norepinephrine transporter inhibition promotes improvement in cognitive task performance in rodent and non-human primate models of Parkinson's disease
Jay S. Schneider, Courtney A. Marshall, Lauren Keibel, et al.
Experimental Neurology (2020) Vol. 335, pp. 113514-113514
Open Access | Times Cited: 23
Exploring the association between cancer and cognitive impairment in the Australian Imaging Biomarkers and Lifestyle (AIBL) study
Liwei Ma, Yi Ling Clare Low, Yuanhao Zhuo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Machine learning for predicting cognitive decline within five years in Parkinson’s disease: Comparing cognitive assessment scales with DAT SPECT and clinical biomarkers
Arman Gorji, Ali Fathi Jouzdani
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0304355-e0304355
Open Access | Times Cited: 2
Subjective Cognitive Complaints in Newly-Diagnosed Parkinson’s Disease With and Without Mild Cognitive Impairment
Chenxi Pan, Jingru Ren, Ping Hua, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 17
Fibrinogen and Complement Factor H Are Promising CSF Protein Biomarkers for Parkinson’s Disease with Cognitive Impairment─A Proteomics–ELISA-Based Study
Aditi Naskar, Albert Stezin, Arpitha Dharmappa, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 7, pp. 1030-1045
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top